Skip to content
Search

Latest Stories

India jinx over but long way to go, Babar tells Pakistan

India jinx over but long way to go, Babar tells Pakistan

PAKISTAN finally got the monkey off their back with a 10-wicket thumping of arch-rivals India but skipper Babar Azam refused to get carried away and reminded his jubilant teammates to stay focused on the task ahead at the Twenty20 World Cup.

Babar led by example as Pakistan outclassed neighbours India in a World Cup showdown for the first time in their 13th attempt, triggering wild celebrations at the Dubai International Stadium on Sunday (24).


"We prepared well, and just kept the history out of our mind," Babar, who combined with opening partner Mohammad Rizwan to chase down the target, said after the memorable victory.

"We applied our plans and got the results. We, the openers, kept it simple and built a partnership and because the wicket was getting better so we just wanted to keep batting till the end."

The 2009 champions face New Zealand in their next Group II assignment on Tuesday (26) and Babar warned his teammates against dropping their intensity.

"It won't get easier just because we beat India," said the elegant opener.

"We will take the confidence, but we're taking it one match at a time, and there's a long way to go in the tournament."

Shaheen Afridi was adjudged man-of-the-match for his 3-31, which included the prize wicket of India captain Virat Kohli, who topscored for his side with a classy 57.

Afridi rattled India early with the new ball, dismissing openers Rohit Sharma and KL Rahul in his successive overs to deny them a strong start.

"It was a historic moment for all of us," Afridi told reporters.

"This was the first time I bowled three overs on the trot in powerplay. I got some swing in the first two overs and my effort was to earn quick breakthroughs for my side which, fortunately, I was able to achieve.

"Bowling yorker with the new ball has been my strength and I tried the same against Rohit. It luckily worked.

"Batting against the new ball was tough, so credit goes to Babar and Rizwan for the way they played."

(Reuters)

More For You

Akshay Kumar hits back at Jaya Bachchan’s ‘flop film’

Akshay Kumar at the Kesari Chapter 2 press event, addressed Jaya Bachchan’s criticism of Toilet: Ek Prem Katha and defended his socially driven films

Getty Images/ Sunday Guardian

Akshay Kumar hits back at Jaya Bachchan’s ‘flop film’ remark: ‘Only a fool would criticise such films’

At a press event for his upcoming film Kesari Chapter 2, Akshay Kumar was asked about recent remarks made by veteran actor and politician Jaya Bachchan, who criticised the title of his 2017 movie Toilet: Ek Prem Katha. Jaya Bachchan had dismissed the film during a public interaction, saying she would never watch a movie with such a title. “Is that even a name for a film?” she asked the audience, adding that the film was a “flop” based on the crowd’s lukewarm response when asked if they had seen it.

Caught off guard, Akshay Kumar initially said he wasn’t aware of the comment but responded with a measured tone: “If she’s said something, maybe she’s right. If making Toilet: Ek Prem Katha was a mistake, then I’ll accept that.”
However, he also stood by the intention behind the film. “I’ve made movies like Pad Man, Airlift, Kesari, all with a purpose. I make these films with full honesty. They try to raise awareness, and I believe that counts,” he added. He stressed that films like Toilet and Pad Man are still used by the government to educate people in villages, showing their long-term impact.

Keep ReadingShow less
Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less

Yvonne Strahovski reveals shocking ending for 'The Handmaid’s Tale' final season, calls it the rebellion

Yvonne Strahovski hints at a thrilling conclusion in The Handmaid’s Tale final season, teasing shocking twists and emotional turns

Getty/Instagram

Yvonne Strahovski reveals shocking ending for 'The Handmaid’s Tale' final season, calls it the rebellion

As The Handmaid’s Tale wraps up its long and intense run, Yvonne Strahovski has given a glimpse into what’s coming next and it sounds like fans should brace themselves. Talking about the sixth and final season, Strahovski hinted at dramatic turns, especially when it comes to Serena Joy Waterford, the controversial character she’s played since the beginning.

In a chat on CBS Mornings Plus, Strahovski didn’t confirm any clear direction for Serena, but she did say that this season might be the character’s biggest reckoning yet. “This is probably Serena’s biggest opportunity to truly face the weight of her actions,” she said. Whether that leads to redemption or a deeper descent remains to be seen, but it’s clear her arc is far from over.

Keep ReadingShow less
Eric Dane

There is currently no cure for ALS

Getty

Grey’s Anatomy and Euphoria star Eric Dane diagnosed with ALS

Eric Dane, best known for his roles in Grey’s Anatomy and Euphoria, has revealed he has been diagnosed with amyotrophic lateral sclerosis (ALS).

ALS, also referred to as motor neurone disease (MND) in the UK, is an incurable condition that progressively damages nerve cells in the brain and spinal cord, leading to increasing muscle paralysis. The disease affects around 153,000 people in the UK, though awareness of its wider range of symptoms remains relatively low.

Keep ReadingShow less